Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
immunosuppressant
|
| gptkbp:activeIngredient |
gptkb:tacrolimus
|
| gptkbp:approvedBy |
gptkb:FDA
gptkb:EMA 2013 |
| gptkbp:ATCCode |
L04AD02
|
| gptkbp:form |
extended-release capsule
|
| https://www.w3.org/2000/01/rdf-schema#label |
Astagraf XL
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Astellas_Pharma
|
| gptkbp:mechanismOfAction |
immunosuppressant
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
hypertension
tremor nephrotoxicity hyperglycemia increased risk of infection |
| gptkbp:tradenameOf |
gptkb:tacrolimus_extended-release
|
| gptkbp:usedFor |
kidney transplant
prevention of organ rejection |
| gptkbp:bfsParent |
gptkb:Prograf
|
| gptkbp:bfsLayer |
6
|